뉴스벤징가
Cullinan Therapeutics Zipalertinib Combo Clears Key Phase 3 Hurdle As First-Line Lung Cancer Treatment Option Takes Shape
· 발표
기사 요약
Cullinan Therapeutics and Taiho report positive Phase 3 trial results for zipalertinib in treating advanced lung cancer.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…